{"DataElement":{"publicId":"6043414","version":"1","preferredName":"Pancreatic Carcinoma Histology Code","preferredDefinition":"A coded response used to determine the microscopic process of identifying normal and abnormal morphologic characteristics in a carcinoma arising from the exocrine pancreas.","longName":"6043413v1.0:6043406v1.0","context":"ECOG-ACRIN","contextVersion":"1","DataElementConcept":{"publicId":"6043413","version":"1","preferredName":"Pancreatic Carcinoma Histology","preferredDefinition":"A carcinoma arising from the exocrine pancreas. The overwhelming majority of pancreatic carcinomas are adenocarcinomas._The study of the structure of the cells and their arrangement to constitute tissues and, finally, the association among these to form organs.  In pathology, the microscopic process of identifying normal and abnormal morphologic characteristics in tissues, by employing various cytochemical and immunocytochemical stains.","longName":"6043411v1.0:2186387v1.0","context":"ECOG-ACRIN","contextVersion":"1","ObjectClass":{"publicId":"6043411","version":"1","preferredName":"Pancreatic Carcinoma","preferredDefinition":"A carcinoma arising from the exocrine pancreas. The overwhelming majority of pancreatic carcinomas are adenocarcinomas.","longName":"C3850","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Pancreatic Carcinoma","conceptCode":"C3850","definition":"A carcinoma arising from the exocrine pancreas. The overwhelming majority of pancreatic carcinomas are adenocarcinomas.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"60A239BA-4111-38F5-E053-F662850AE6C5","latestVersionIndicator":"Yes","beginDate":"2017-12-18","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2017-12-18","modifiedBy":"ONEDATA","dateModified":"2017-12-18","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2186387","version":"1","preferredName":"Histology","preferredDefinition":"The study of the structure of the cells and their arrangement to constitute tissues and, finally, the association among these to form organs.  In pathology, the microscopic process of identifying normal and abnormal morphologic characteristics in tissues, by employing various cytochemical and immunocytochemical stains.","longName":"C16681","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Histology","conceptCode":"C16681","definition":"The study of the structure of the cells and their arrangement to constitute tissues and, finally, the association among these to form organs.  In pathology, the microscopic process of identifying normal and abnormal morphologic characteristics in tissues, by employing various cytochemical and immunocytochemical stains.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"E0647F5B-A9B0-4B87-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2004-08-03","endDate":null,"createdBy":"REEVESD","dateCreated":"2004-08-03","modifiedBy":"DWARZEL","dateModified":"2023-04-12","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008537","version":"1","preferredName":"Diagnosis","preferredDefinition":"the process of identifying a disease by the signs and symptoms (NCI Glossary).","longName":"DX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B205508C-8324-69B0-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-17","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-17","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"ECOG CRF:Eastern Cooperative Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"60A239BA-411F-38F5-E053-F662850AE6C5","latestVersionIndicator":"Yes","beginDate":"2017-12-18","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2017-12-18","modifiedBy":"GARRIDOJ","dateModified":"2017-12-18","changeDescription":"Created for EA2161, 12/18/2017 JG","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"6043406","version":"1","preferredName":"Pancreatic Histology Code","preferredDefinition":"A symbol or combination of symbols which is assigned to the members of a collection.","longName":"6043406v1.0","context":"ECOG-ACRIN","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":"1","maxLength":"2","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"88","valueDescription":"Other","ValueMeaning":{"publicId":"2559653","version":"1","preferredName":"Other","longName":"2559653","preferredDefinition":"Different than the one(s) previously specified or mentioned.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Other","conceptCode":"C17649","definition":"Different than the one(s) previously specified or mentioned.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-B612-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2002-02-13","endDate":null,"createdBy":"SBR","dateCreated":"2002-02-13","modifiedBy":"GDEEN","dateModified":"2023-12-28","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"60A2E2DC-8FE5-0D00-E053-F662850A3E8D","beginDate":"2017-12-18","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2017-12-18","modifiedBy":"ONEDATA","dateModified":"2017-12-18","deletedIndicator":"No"},{"value":"6","valueDescription":"Small cell carcinoma","ValueMeaning":{"publicId":"2567204","version":"1","preferredName":"Small cell carcinoma","longName":"2567204","preferredDefinition":"A neuroendocrine carcinoma composed of small malignant cells which are often said to resemble \"oat cells\" under the microscope.  Small cell carcinoma most often affects the lungs.  Clinically, this is often a rapidly growing cancer that spreads to distant sites early.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Small Cell Neuroendocrine Carcinoma","conceptCode":"C3915","definition":"An aggressive, high-grade, and poorly differentiated carcinoma with neuroendocrine differentiation. It is composed of malignant small cells.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-D391-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2003-11-14","endDate":null,"createdBy":"SBREXT","dateCreated":"2003-11-14","modifiedBy":"REEVESD","dateModified":"2016-04-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"60A2E2DC-8FF9-0D00-E053-F662850A3E8D","beginDate":"2017-12-18","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2017-12-18","modifiedBy":"ONEDATA","dateModified":"2017-12-18","deletedIndicator":"No"},{"value":"5","valueDescription":"Goblet Cell Carcinoid Tumor","ValueMeaning":{"publicId":"6043407","version":"1","preferredName":"Goblet Cell Carcinoid Tumor","longName":"6043407","preferredDefinition":"A mucin-producing and -secreting epithelial cell found mainly in the intestinal and respiratory tracts.: A slow growing neuroendocrine tumor, composed of uniform, round, or polygonal cells having monotonous, centrally located nuclei and small nucleoli, infrequent mitoses, and no necrosis.  The tumor may show a variety of patterns, such as solid, trabecular, and acinar.  Electron microscopy shows small secretory granules.  Immunohistochemical studies reveal NSE, as well as chromogranin immunoreactivity.  Malignant histology (cellular pleomorphism, hyperchromatic nuclei, prominent nucleoli, necrosis, and mitoses) can occasionally be seen.  Such cases may have an aggressive clinical course.  Gastrointestinal tract and lung are common sites of involvement.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Goblet Cell","conceptCode":"C12586","definition":"A mucin-producing and -secreting epithelial cell found mainly in the intestinal and respiratory tracts.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Carcinoid Tumor","conceptCode":"C2915","definition":"A slow growing neuroendocrine tumor, composed of uniform, round, or polygonal cells having monotonous, centrally located nuclei and small nucleoli, infrequent mitoses, and no necrosis.  The tumor may show a variety of patterns, such as solid, trabecular, and acinar.  Electron microscopy shows small secretory granules.  Immunohistochemical studies reveal NSE, as well as chromogranin immunoreactivity.  Malignant histology (cellular pleomorphism, hyperchromatic nuclei, prominent nucleoli, necrosis, and mitoses) can occasionally be seen.  Such cases may have an aggressive clinical course.  Gastrointestinal tract and lung are common sites of involvement.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"60A2E2DC-9006-0D00-E053-F662850A3E8D","latestVersionIndicator":"Yes","beginDate":"2017-12-18","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2017-12-18","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"60A2E2DC-9021-0D00-E053-F662850A3E8D","beginDate":"2017-12-18","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2017-12-18","modifiedBy":"ONEDATA","dateModified":"2017-12-18","deletedIndicator":"No"},{"value":"4","valueDescription":"Combined Carcinoid and Adenocarcinoma","ValueMeaning":{"publicId":"6043409","version":"1","preferredName":"Combined Carcinoid and Adenocarcinoma","longName":"6043409","preferredDefinition":"A malignant epithelial neoplasm composed of a mixture of neuroendocrine cells with morphologic and immunohistochemical characteristics of carcinoid tumor and malignant glandular cells.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Combined Carcinoid and Adenocarcinoma","conceptCode":"C4139","definition":"A malignant epithelial neoplasm composed of a mixture of neuroendocrine cells with morphologic and immunohistochemical characteristics of carcinoid tumor and malignant glandular cells.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"60A2E2DC-902E-0D00-E053-F662850A3E8D","latestVersionIndicator":"Yes","beginDate":"2017-12-18","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2017-12-18","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"60A2E2DC-9049-0D00-E053-F662850A3E8D","beginDate":"2017-12-18","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2017-12-18","modifiedBy":"ONEDATA","dateModified":"2017-12-18","deletedIndicator":"No"},{"value":"3","valueDescription":"High Grade Neuroendocrine Carcinoma","ValueMeaning":{"publicId":"6043410","version":"1","preferredName":"High Grade Neuroendocrine Carcinoma","longName":"6043410","preferredDefinition":"Used to describe tumor samples that exhibit poorly differentiated or undifferentiated cells. They are generally expected to be fast growing and aggressive.: A malignant neuroendocrine neoplasm composed of cells containing secretory granules that stain positive for NSE and chromogranin.  The neoplastic cells are often round and form clusters or trabecular sheets.  Representative examples are small cell carcinoma, large cell neuroendocrine carcinoma, and Merkel cell carcinoma.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"High Grade","conceptCode":"C14158","definition":"Used to describe tumor samples that exhibit poorly differentiated or undifferentiated cells. They are generally expected to be fast growing and aggressive.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Neuroendocrine Carcinoma","conceptCode":"C3773","definition":"A usually aggressive carcinoma composed of malignant cells exhibiting neuroendocrine differentiation.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"60A2E2DC-9056-0D00-E053-F662850A3E8D","latestVersionIndicator":"Yes","beginDate":"2017-12-18","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2017-12-18","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"60A2E2DC-9071-0D00-E053-F662850A3E8D","beginDate":"2017-12-18","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2017-12-18","modifiedBy":"ONEDATA","dateModified":"2017-12-18","deletedIndicator":"No"},{"value":"2","valueDescription":"Poorly Differentiated Neuroendocrine Carcinoma","ValueMeaning":{"publicId":"6029501","version":"1","preferredName":"Poorly Differentiated Neuroendocrine Carcinoma","longName":"6029501","preferredDefinition":"Describes tumor cells that generally have lost most of the appearance of normal cells. They tend to grow and spread.: A malignant neuroendocrine neoplasm composed of cells containing secretory granules that stain positive for NSE and chromogranin.  The neoplastic cells are often round and form clusters or trabecular sheets.  Representative examples are small cell carcinoma, large cell neuroendocrine carcinoma, and Merkel cell carcinoma.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Poorly Differentiated","conceptCode":"C14167","definition":"Describes tumor cells that generally have lost most of the appearance of normal cells. They tend to grow and spread.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Neuroendocrine Carcinoma","conceptCode":"C3773","definition":"A usually aggressive carcinoma composed of malignant cells exhibiting neuroendocrine differentiation.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"5E24E01C-BE0D-1608-E053-F662850A1B5E","latestVersionIndicator":"Yes","beginDate":"2017-11-16","endDate":null,"createdBy":"COOPERM","dateCreated":"2017-11-16","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"60A2E2DC-9087-0D00-E053-F662850A3E8D","beginDate":"2017-12-18","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2017-12-18","modifiedBy":"ONEDATA","dateModified":"2017-12-18","deletedIndicator":"No"},{"value":"1","valueDescription":"Pancreatic Neuroendocrine Tumor","ValueMeaning":{"publicId":"3250495","version":"1","preferredName":"Pancreatic Neuroendocrine Tumor","longName":"3250495","preferredDefinition":"A low or intermediate grade well differentiated tumor with neuroendocrine differentiation that arises from the pancreas.  According to the presence or absence of clinical syndromes that result from hormone hypersecretion, pancreatic neuroendocrine tumors are classified either as functional or nonfunctional.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Pancreatic Neuroendocrine Tumor","conceptCode":"C27720","definition":"A well differentiated, low, intermediate, or high grade neoplasm with neuroendocrine differentiation that arises from the pancreas.  According to the presence or absence of clinical syndromes that result from hormone hypersecretion, pancreatic neuroendocrine tumors are classified either as functional or nonfunctional.","evsSource":"CTCAE_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A6F215E6-C657-B293-E040-BB89AD432EF3","latestVersionIndicator":"Yes","beginDate":"2011-06-30","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-06-30","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"60A2E2DC-909C-0D00-E053-F662850A3E8D","beginDate":"2017-12-18","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2017-12-18","modifiedBy":"ONEDATA","dateModified":"2017-12-18","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008537","version":"1","preferredName":"Diagnosis","preferredDefinition":"the process of identifying a disease by the signs and symptoms (NCI Glossary).","longName":"DX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B205508C-8324-69B0-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-17","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-17","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"2261841","version":"1","preferredName":"Code","preferredDefinition":"A system of numbered categories for representation of data.","longName":"C25162","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Code","conceptCode":"C25162","definition":"A symbol or combination of symbols which is assigned to the members of a collection.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Standard","id":"FBB87F7A-6427-1AFC-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-07-13","endDate":null,"createdBy":"MAESKEB","dateCreated":"2005-07-13","modifiedBy":"SBR","dateModified":"2005-09-08","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"ECOG CRF:Eastern Cooperative Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"60A2E2DC-8FCC-0D00-E053-F662850A3E8D","latestVersionIndicator":"Yes","beginDate":"2017-12-18","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2017-12-18","modifiedBy":"GARRIDOJ","dateModified":"2017-12-18","changeDescription":"Created for EA2161, 12/18/2017 JG","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"3314482","version":"1","longName":"Type of Category","context":"ECOG-ACRIN","ClassificationSchemeItems":[{"publicId":"5936696","version":"1","longName":"Disease Assessment ","context":"ECOG-ACRIN"}]}],"AlternateNames":[],"ReferenceDocuments":[{"name":"Histology","type":"Preferred Question Text","description":"Histology","url":null,"context":"ECOG-ACRIN"}],"origin":"ECOG CRF:Eastern Cooperative Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"60A301A9-63D6-1489-E053-F662850A3070","latestVersionIndicator":"Yes","beginDate":"2017-12-18","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2017-12-18","modifiedBy":"GARRIDOJ","dateModified":"2017-12-18","changeDescription":"Created for EA2161, 12/18/2017 JG","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}